Iodine I 123 anti-CEA recombinant diabody T84.66
N/A
Report date: 2025/10/20 14:38:44
Base Information
Drug NameIodine I 123 anti-CEA recombinant diabody T84.66
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical CenterNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteCity Of Hope National Medical Center
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A